Can you vaccinate against substance abuse?

Bibliography

• United Nations Office on Drugs and Crime: UNODC. World Drug Report 2010 (United Nations Publication, Sales No. E.10.XI.13). Available from: http://www.unodc.org/documents/wdr/WDR_2010/World_Drug_Report_2010_lo-res.pdf
   Google Scholar
• Shen XY, Orson FM, Kosten TR. Vaccines against drug abuse. Clin Pharmacol Ther 2012;91(1):60-70
   PubMed Web of Science ®Google Scholar
• Stotts AL, Dodrill CL, Kosten TR. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother 2009;10(11):1727-40
   PubMed Web of Science ®Google Scholar
• Orson FM, Kinsey BM, Singh RA, et al. The future of vaccines in the management of addictive disorders. Curr Psychiatry Rep 2007;9(5):381-7
   PubMedGoogle Scholar
• Veilleux JC, Colvin PJ, Anderson J, et al. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev 2010;30(2):155-66
   PubMed Web of Science ®Google Scholar
• Kahan M, Srivastava A, Ordean A, Cirone S. Buprenorphine: new treatment of opioid addiction in primary care. Can Fam Physician 2011;57(3):281-9
   PubMed Web of Science ®Google Scholar
• Kreek MJ, Borg L, Ducat E, Ray B. Pharmacotherapy in the treatment of addiction: methadone. J Addict Dis 2010;29(2):200-16
   PubMed Web of Science ®Google Scholar
• Obadia Y, Perrin V, Feroni I, et al. Injecting misuse of buprenorphine among French drug users. Addiction 2001;96(2):267-72
   PubMed Web of Science ®Google Scholar
• Inturrisi CE, Schultz M, Shin S, et al. Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci 1983;33(Suppl 1):773-6
   PubMed Web of Science ®Google Scholar
• Kosten TR, Newton TF, De La Garza R II, Haile CN. Cocaine and methamphetamine dependence: advances in treatment. APPI Press, Arlington, VA; 2012; ISBN-10:1585624071
   Google Scholar
• Woolverton WL, Wang Z. Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine. Eur J Pharmacol 2004;486:251-7
   PubMed Web of Science ®Google Scholar
• De Wit H, Bodker B, Ambre J. Rate of increase of plasman drug level influences subjective response in humans. Psychopharmacology (Berl) 1992;107:352-8
   PubMed Web of Science ®Google Scholar
• Marsch LA, Bickel WK, Badger GJ, et al. Effects of infusion rate of intravenously administered morphine on physiology, psychomotor, and self-reported measures in humans. J Pharmacol Exp Ther 2001;299:1056-65
   PubMed Web of Science ®Google Scholar
• Shen X, Kinsey B, Lopez Y, et al. Evaluation of peptide and conjugate morphine vaccines in mice. College on Problems of Drug Dependence, 74th Annual Meeting; Palm Springs, CA. Poster Session; 2012
   Google Scholar
• Ringle DA, Herndon BL. Immunologic effects of morphine administration in rabbits. J Immunol 1975;115:876-83
   PubMed Web of Science ®Google Scholar
• Deng SX, Bharat N, Fishman MC, Landry DW. Covalent modification of proteins by cocaine. Proc Natl Acad Sci 2002;99:3412-16
   PubMed Web of Science ®Google Scholar
• Orson FM, Rossen RD, Shen XY, et al. Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to cocaine - cholera toxin b conjugate vaccine. Amer J Addiction 2013;22(2):169-74
   PubMed Web of Science ®Google Scholar
• Toki S, Yamano S. Production of morphinone as a metabolite of morphine and its physiological role. Yakugaku Zasshi 1999;119(4):249-67
   PubMed Web of Science ®Google Scholar
• Biagini RE, Klincewicz SL, Henningsen GM, et al. Antibodies to morphine in workers exposed to opiates at a narcotics manufacturing facility and evidence for similar antibodies in heroin abusers. Life Sci 1990;47:897-908
   PubMed Web of Science ®Google Scholar
• Dani JA, Kosten TR, Benowitz N. Nicotine and tobacco: pharmacology. In: Ries RK, Fiellin DA, Miller S, Saitz R, editors. Principles of addiction medicine. 4th edition. Kosten Pharmacology editor Lippincott Williams & Wilkins, Philadelphia, PA; 2009; ISBN-10: 0-7817-7477-2
   Google Scholar
• Berkowitz B, Spector S. Evidence for active immunity to morphine in mice. Science 1972;178(67):1290-2
   PubMedGoogle Scholar
• Bonese KF, Wainer BH, Fitch FW, et al. Changes in heroin self-administration by a rhesus monkey after morphine immunization. Nature 1974;252(5485):708-10
   PubMed Web of Science ®Google Scholar
• Gentry WB, Ruedi-Bettschen D, Owens SM. Development of active and passive human vaccines to treat methamphetamine addiction. Hum Vaccin 2009;5(4):206-13
   PubMed Web of Science ®Google Scholar
• Van Vunakis H, Wasserman E, Levine L. Specificities of antibodies to morphine. J Pharmacol Exp Ther 1972;180(2):514-21
   PubMed Web of Science ®Google Scholar
• Wainer BH, Fitch FW, Fried J, Rothberg RM. A measurement of the specificities of antibodies to morphine-6-succinyl-BSA by competitive inhibition of 14 C-morphine binding. J Immunol 1973;110(3):667-73
   PubMed Web of Science ®Google Scholar
• Koida M, Takahashi M, Muraoka S, Kaneto H. Antibodies to BSA conjugates of morphine derivatives: strict dependency of the immunological specificity on the hapten structure. Jpn J Pharmacol 1974;24(1):165-7
   PubMedGoogle Scholar
• Anton B, Leff P. A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents. Vaccine 2006;24(16):3232-40
   PubMed Web of Science ®Google Scholar
• Anton B, Salazar A, Flores A, et al. Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors. Hum Vaccin 2009;5(4):214-29
   PubMed Web of Science ®Google Scholar
• Stowe GN, Vendruscolo LF, Edwards S, et al. A vaccine strategy that induces protective immunity against heroin. J Med Chem 2011;54(14):5195-204
   PubMed Web of Science ®Google Scholar
• Bagasra O, Forman LJ, Howeedy A, Whittle P. A potential vaccine for cocaine. Immunopharmacology 1992;23:173-9
   PubMed Web of Science ®Google Scholar
• Martell BA, Orson FM, Poling J, et al. Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. ArchGen Psychiatry 2009;66:1116-23
   PubMed Web of Science ®Google Scholar
• Kosten TR, Rosen M, Bond J, et al. Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine 2002;20:1196-204
   PubMed Web of Science ®Google Scholar
• Martell BA, Mitchell E, Poling J, et al. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry 2005;58:158-64
   PubMed Web of Science ®Google Scholar
• Haney M, Gunderson EW, Jiang H, et al. Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans. Biol Psychiatry 2010;67(1):59-65
   PubMed Web of Science ®Google Scholar
• Ishizaka ST, Hawkins LD. E6020: a synthetic toll-like receptor 4 agonist as a vaccine adjuvant. Expert Rev Vaccines 2007;6(5):773-84
   PubMed Web of Science ®Google Scholar
• Shen XY, Kosten TA, Lopez AY, et al. A vaccine against methamphetamine attenuates its behavioral effects in mice. Drug Alcohol Dependence 2012;129(1-2):41-8
   PubMed Web of Science ®Google Scholar
• Hatsukami DK, Jorenby DE, Gonzales D, et al. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther 2011;89:392-9
   PubMed Web of Science ®Google Scholar